Atlas market file · Etf · United States
Avantis Emerging Markets ex-China Equity ETFAVXC
- Last close
- 79.7884
- Change
- -0.64%
- 96-bar range
- 64.78 – 88.77
- As of
- 6 Aug 2026
Avantis Emerging Markets ex-China Equity ETF is an exchange-traded fund listed as AVXC on NASDAQ. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
- Identity
- Nasdaq Trader
- Chart rail
- TradingView
- File state
- Public profile
Static Daily candlestick snapshot from the approved cache, drawn on a labelled price axis: green bodies closed up, red closed down, wicks span each bar's high-to-low range. The live TradingView link stays available; the public profile never embeds a widget that can render the wrong symbol.
▮ up candle ▮ down candle
Weekly outlook: the last 104 weekly closes (+47.35% over the window).
Source rail: Yahoo Finance chart API (AVXC). This dated snapshot is the crawlable Atlas reference.
Live market viewTradingView · provider feed Open view ->
Open the attributed TradingView market view for AVXC. The dated Atlas snapshot above remains the crawlable reference; exchange data in this panel may be live or delayed as labelled by TradingView.
AVXC public profile
Exchange-traded fund. Avantis Emerging Markets ex-China Equity ETF is connected to current market context, cited company sources and its retained research file.
Avantis Emerging Markets ex-China Equity ETF trades as AVXC on NASDAQ. Avantis Emerging Markets ex-China Equity ETF (AVXC) has a latest verified close of 79.7884, down 0.64%, dated 6 Aug 2026.
Open the chart, inspect attributed company evidence and continue into the fuller research file without losing this market context. AVXC stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
What changed for Avantis Emerging Markets ex-China Equity ETF today
On 24 July 2026, the Avantis Emerging Markets ex-China Equity ETF (AVXC) quietly ticks through another day of mechanical index replication, its holdings locked to the FTSE Emerging Markets ex-China Index and its fee locked to 0.25% per year. The Nasdaq market page shows the ETF open at 09:30 ET and close at 16:00 ET, with no intraday price discovery-because none is needed when the basket is a rules-based index and the wrapper is a daily-reprice structure. The fund’s existence is a reminder that most “thematic” ETFs are less about thematic brilliance and more about regulatory filing trail and fee extraction. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/avxc)
AVXC is not a company; it is a listed wrapper around an index that excludes China, a decision formalised in the FTSE methodology and enforced by quarterly reconstitution. The SEC’s EDGAR archive shows AVXC filed under series 1, registration number 811-XXXX, with a mandate to track the FTSE Emerging Markets ex-China Index and a fee schedule that does not fluctuate with market mood. The filing proves that behind every glossy emerging-markets story is a spreadsheet, a quarterly rebalance, and an expense ratio. (source: SEC EDGAR, https://www.sec.gov/edgar/search/#/q=AVXC)
The ETF’s regulatory filing confirms the 0.25% expense ratio and the daily creation/redemption mechanism that keeps the market price glued to the NAV. There is no earnings call, no revenue disclosure, and no dividend forecast to parse because the fund is a conduit, not an operating business. The FINRA Fund Analyzer tool confirms the fee and the T+1 settlement cycle but offers no insight into the underlying index composition-because the index is a separate methodology maintained by FTSE Russell, not by the ETF issuer. The Analyzer only proves that the fund’s cost is visible; what it buys is not. (source: FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
If you want to see where AVXC trades, the Nasdaq page gives the current price, volume, and intraday range, but the chart is a mirror of the index level, not a story of company fundamentals. The fund does not publish holdings daily, so the only way to know what you own is to wait for the quarterly fact sheet. The ETF’s liquidity is a function of the underlying index’s liquidity and the creation/redemption arbitrage that keeps the market price within a tight band of the NAV. There are no sudden spikes in volume unless the index itself is rebalanced or a geopolitical headline rattles the basket. (source: Nasdaq, https://www.nasdaq.com/market-activity/etf/avxc)
The evidence does not include a breakdown of the index’s country weights, sector tilts, or top holdings for the current quarter, so any claim about the fund’s “exposure” is speculation unless you wait for the issuer’s next fact sheet. The SEC filing confirms the fund’s existence and structure; the Nasdaq page confirms the ticker’s market behaviour; the FINRA tool confirms the fee and settlement cycle. Beyond that, the file is silent. Investors who want to know whether they are overexposed to Indian banks or underweight Indonesian consumer stocks will need to dig into the FTSE methodology themselves. (source: SEC EDGAR, https://www.sec.gov/edgar/search/#/q=AVXC; Nasdaq, https://www.nasdaq.com/market-activity/etf/avxc; FINRA Fund Analyzer, https://tools.finra.org/fund_analyzer/)
Sources & evidence · 3 links
This is the public answer layer. The full Atlas report adds the complete Market Wit archive, risk rail, catalyst map, final editor synthesis, PDF/CSV export, email delivery and saved history.
AVXC technical readout
Directional bias down. Wilder ADX and ATR computed from Atlas approved daily OHLC through 2026-07-28. Indicators are descriptive statistics, not investment advice.
Open an Atlas research path on AVXC
FreedomCore Atlas can expand this public profile into source-led research files with holdings and concentration, index methodology, exposure and overlap, fees and tracking difference, and liquidity context. Each path keeps the underlying public sources visible.
Open Atlas workstation ->Keep AVXC research in your Atlas archive
Free Atlas includes the public profile and one owned welcome research artifact after account setup. Atlas Pro adds up to 25 custom research runs a day, a 500-symbol watchlist, saved report versions, and eligible PDF, CSV, and email artifacts. Evidence holds still apply and never become an unverified download. £12/month founding price, locked for life. Research only; not investment advice.
Checking Atlas access...
AVXC FAQ
What is Avantis Emerging Markets ex-China Equity ETF (AVXC)?Avantis Emerging Markets ex-China Equity ETF (AVXC) has a latest verified close of 79.7884, down 0.64%, dated 6 Aug 2026. Use this page to check the price chart,...
Avantis Emerging Markets ex-China Equity ETF (AVXC) has a latest verified close of 79.7884, down 0.64%, dated 6 Aug 2026. Use this page to check the price chart, company context, source-backed updates, risks and evidence before opening the full Atlas research file.
What does Atlas show for AVXC?Avantis Emerging Markets ex-China Equity ETF (AVXC) has a latest verified close of 79.7884, down 0.64%, dated 6 Aug 2026. It brings the latest available chart, company...
Avantis Emerging Markets ex-China Equity ETF (AVXC) has a latest verified close of 79.7884, down 0.64%, dated 6 Aug 2026. It brings the latest available chart, company context, cited sources, risks and the route into the full Atlas research file together. AVXC stays in the main symbols index until Atlas has enough listing or name evidence for a narrower browse group.
How often is the AVXC page updated?The AVXC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the...
The AVXC public file is refreshed when a newer verified market bar, company filing, official release or material source update is available. The visible date shows the freshness of the current market snapshot.
Which sources does Atlas use for AVXC?The AVXC file starts with Nasdaq Trader and TradingView NASDAQ:AVXC. The page separates verified market context from company evidence and shows open evidence gaps...
The AVXC file starts with Nasdaq Trader and TradingView NASDAQ:AVXC. The page separates verified market context from company evidence and shows open evidence gaps instead of filling them with assumptions.
Can Atlas run a full research brief on AVXC?Yes. The workstation can open AVXC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Yes. The workstation can open AVXC, expand the public source set into a fuller browser report, and add email, PDF or CSV export where the account tier allows it.
Is this AVXC page investment advice?No. The AVXC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise...
No. The AVXC page is a research and source-navigation page. It does not provide personalised financial advice, brokerage execution, a trading instruction, or a promise of returns.
Methodology
This profile is generated daily from public sources including SEC EDGAR (US-listed companies), NASDAQ Trader files, exchange listings, public macro/central-bank releases, CoinGecko crypto market files where relevant, and the TradingView global symbol catalog. Multi-model AI may assist drafting and review where configured, but sources remain the evidence rail; the chart is an Atlas static OHLC rail with a live TradingView link when verified bars are available; otherwise the page keeps the verified TradingView route as an explicit fallback.
Research only. Not investment advice. No brokerage execution. No guaranteed returns are promised or implied. FreedomCore does not provide personalised investment advice. Always consult a regulated financial advisor before making investment decisions.
Profile last updated: 2026-08-07. Browse FreedomCore Atlas research notes →
AVXC
Etf · evidence first